isostearate has been researched along with imiquimod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chollet, JL; Jozwiakowski, MJ; Phares, KR; Reiter, MJ; Roddy, PJ; Schultz, HJ; Ta, QV; Tomai, MA | 1 |
| Burnet, M; Cloos, N; Cruces, S; Fischer, T; Geiger, J; Geiger, S; Guezguez, J; Guse, JH; Keppler, M; Laufer, S; Martorelli, M; Riexinger, L; Sandri, TL; Schwamborn, A; Späth, N; Straß, S | 1 |
2 other study(ies) available for isostearate and imiquimod
| Article | Year |
|---|---|
Development of a topically active imiquimod formulation.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Chemistry, Pharmaceutical; Cytokines; Emulsions; Excipients; Gels; Hydrogen-Ion Concentration; Imiquimod; Male; Mice; Mice, Hairless; Molecular Structure; Ointments; Skin; Solubility; Stearic Acids; Surface-Active Agents; Suspensions; Temperature | 1999 |
Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models.
Topics: Animals; Cytokines; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Mice; Mice, Inbred BALB C; Skin; Toll-Like Receptor 7 | 2023 |